Overview
Ring chromosome 20 syndrome (r(20) syndrome) is a rare chromosomal disorder caused by the formation of a ring-shaped chromosome 20, in which the two ends of the chromosome fuse together, often with loss of genetic material at the tips. This condition primarily affects the nervous system and is characterized by refractory epilepsy, which is often the hallmark feature. Seizures typically begin in childhood and are frequently resistant to standard antiepileptic medications. The most distinctive seizure type associated with this syndrome is prolonged episodes of non-convulsive status epilepticus, often presenting as subtle behavioral changes, confusion, or staring episodes, as well as complex partial seizures, particularly occurring during sleep. Electroencephalographic (EEG) findings often show prolonged episodes of high-voltage slow waves and epileptiform discharges, especially during sleep. Cognitive and behavioral difficulties are common in ring chromosome 20 syndrome. Many affected individuals experience intellectual disability ranging from mild to moderate, though some may have normal intelligence, particularly if the ring chromosome is present in mosaic form (meaning only some cells carry the ring chromosome). Behavioral problems, including attention difficulties, anxiety, and autistic features, have been reported. Some patients may also experience progressive cognitive decline associated with ongoing seizure activity. Dysmorphic facial features are generally absent or very subtle, which can make clinical recognition challenging before genetic testing is performed. There is currently no cure for ring chromosome 20 syndrome. Treatment focuses primarily on seizure management, though epilepsy in this condition is notoriously difficult to control with conventional antiepileptic drugs. Medications such as valproate, lamotrigine, and clobazam may provide partial benefit. Vagus nerve stimulation (VNS) has been explored as an adjunctive therapy in some patients with variable results. The ketogenic diet has also been tried in some cases. Supportive care including educational support, neuropsychological assessment, and behavioral interventions are important components of management. Genetic counseling is recommended for affected families.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Ring chromosome 20 syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ring chromosome 20 syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Ring chromosome 20 syndrome.
Community
No community posts yet. Be the first to share your experience with Ring chromosome 20 syndrome.
Start the conversation →Latest news about Ring chromosome 20 syndrome
No recent news articles for Ring chromosome 20 syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Ring chromosome 20 syndrome
What is Ring chromosome 20 syndrome?
Ring chromosome 20 syndrome (r(20) syndrome) is a rare chromosomal disorder caused by the formation of a ring-shaped chromosome 20, in which the two ends of the chromosome fuse together, often with loss of genetic material at the tips. This condition primarily affects the nervous system and is characterized by refractory epilepsy, which is often the hallmark feature. Seizures typically begin in childhood and are frequently resistant to standard antiepileptic medications. The most distinctive seizure type associated with this syndrome is prolonged episodes of non-convulsive status epilepticus,
How is Ring chromosome 20 syndrome inherited?
Ring chromosome 20 syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Ring chromosome 20 syndrome typically begin?
Typical onset of Ring chromosome 20 syndrome is childhood. Age of onset can vary across affected individuals.
Which specialists treat Ring chromosome 20 syndrome?
15 specialists and care centers treating Ring chromosome 20 syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.